What's in Jiaxing AnDiCon Biotech Co.,Ltd's pipeline?

Jiaxing AnDiCon Biotech Co.,Ltd has 8 drugs in our index: 0 marketed, 0 filed, 6 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with Jiaxing AnDiCon Biotech Co.,Ltd's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, AstraZeneca, BioAtla, Inc., Byondis B.V., Charite University, Berlin, Germany.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiaxing-andicon-biotech-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jiaxing AnDiCon Biotech Co.,Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jiaxing AnDiCon Biotech Co.,Ltd pipeline: 0 marketed, 0 filed, 6 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 6 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Placebo of ADC189 tablets	Placebo of ADC189 tablets	phase 3
Baloxavir Marboxil tablets	Baloxavir Marboxil tablets	phase 3	Cap-dependent endonuclease inhibitor	Influenza PA endonuclease	Virology/Infectious Disease
Placebo of ADC189 granules	Placebo of ADC189 granules	phase 3
Placebo of Baloxavir Marboxil tablets	Placebo of Baloxavir Marboxil tablets	phase 3			Virology/Influenza
ADC189 tablets	ADC189 tablets	phase 3	Antibody-drug conjugate (ADC)		Oncology
ADC189 tablet	ADC189 tablet	phase 3	Antibody-drug conjugate (ADC)		Oncology

Therapeutic area mix

Oncology · 2
Virology/Infectious Disease · 1
Virology/Influenza · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
AstraZeneca · 1 shared drug class
BioAtla, Inc. · 1 shared drug class
Byondis B.V. · 1 shared drug class
Charite University, Berlin, Germany · 1 shared drug class
Gustave Roussy, Cancer Campus, Grand Paris · 1 shared drug class
Medstar Health Research Institute · 1 shared drug class
Amgen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jiaxing AnDiCon Biotech Co.,Ltd:

Cite this brief

Drug Landscape (2026). Jiaxing AnDiCon Biotech Co.,Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiaxing-andicon-biotech-co-ltd. Accessed 2026-05-17.